IPO Monitor
Subscribe Login Login About Us Contact Us Help
Recent Filings - Secondary Offerings
Date Company Location Amount
2022-11-22 Apyx Medical Corp Clearwater, FL $100.0 mil.
 An advanced energy technology company
2022-11-22 SunHydrogen, Inc. Santa Barbara, CA $45.0 mil.
 Provides renewable energy services.
2022-11-22 FTAI Infrastructure Inc. New York, NY $75.0 mil.
 Develops, owns, and invests in essential infrastructure and services
2022-11-22 First Financial Northwest, Inc. Renton, WA $75.0 mil.
 A bank holding company
2022-11-22 Ascend Wellness Holdings, LLC New York, NY $100.0 mil.
 Manufactures and distributes cannabis consumer packaged goods
2022-11-22 Benson Hill, Inc. St. Louis, MO $100.0 mil.
 An integrated food technology company
2022-11-21 The Arena Group Holdings, Inc. New York, NY $250.0 mil.
 A tech-powered media company
2022-11-21 Cassava Sciences, Inc. Austin, TX $50.0 mil.
 A clinical stage biotechnology company.
2022-11-21 Icahn Enterprises L.P. New York, NY $400.0 mil.
 A diversified holding company
2022-11-21 NextPlat Corp Coconut Grove, FL $100.0 mil.
 A global e-commerce platform company
2022-11-21 Surgery Partners, Inc. Nashville, TN $575.0 mil.
 A leading healthcare services company
2022-11-21 OptiNose, Inc. Yardley, PA $50.0 mil.
 A specialty pharmaceutical company
2022-11-21 scPharmaceuticals Inc. Burlington, MA $50.0 mil.
 A pharmaceutical company
2022-11-18 2seventy bio, Inc. Cambridge, MA $150.0 mil.
 A cell and gene therapy company
2022-11-18 Iovance Biotherapeutics, Inc. San Carlos, CA $500.0 mil.
 A clinical-stage biopharmaceutical company
2022-11-18 Enfusion, Inc. Chicago, IL $150.0 mil.
 A global, high-growth software-as-a-service, or SaaS, provider
2022-11-18 PARTS iD, Inc. Cranbury, NJ $16.0 mil.
 A technology-driven, digital commerce company
2022-11-18 Coherus BioSciences, Inc. Redwood City, CA $150.0 mil.
 A late-stage clinical biologics platform company
2022-11-18 Genprex, Inc. Austin, TX $50.0 mil.
 A clinical stage gene therapy company
2022-11-18 Omeros Corp. Seattle, WA $150.0 mil.
 A clinical-stage biopharmaceutical company.
More >>

[ Contact Us | About Us | Site Map ]

Copyright (c) 1998-2022 IPO Monitor. All rights reserved